GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Owens & Minor Inc (NYSE:OMI) » Definitions » ROE %

Owens & Minor (Owens & Minor) ROE % : 7.86% (As of Dec. 2023)


View and export this data going back to 1988. Start your Free Trial

What is Owens & Minor ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Owens & Minor's annualized net income for the quarter that ended in Dec. 2023 was $71 Mil. Owens & Minor's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $906 Mil. Therefore, Owens & Minor's annualized ROE % for the quarter that ended in Dec. 2023 was 7.86%.

The historical rank and industry rank for Owens & Minor's ROE % or its related term are showing as below:

OMI' s ROE % Range Over the Past 10 Years
Min: -56.98   Med: 5.85   Max: 26.85
Current: -4.51

During the past 13 years, Owens & Minor's highest ROE % was 26.85%. The lowest was -56.98%. And the median was 5.85%.

OMI's ROE % is ranked worse than
85.26% of 95 companies
in the Medical Distribution industry
Industry Median: 7.24 vs OMI: -4.51

Owens & Minor ROE % Historical Data

The historical data trend for Owens & Minor's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Owens & Minor ROE % Chart

Owens & Minor Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.72 5.09 26.85 2.38 -4.42

Owens & Minor Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.26 -10.45 -12.41 -2.88 7.86

Competitive Comparison of Owens & Minor's ROE %

For the Medical Distribution subindustry, Owens & Minor's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Owens & Minor's ROE % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Owens & Minor's ROE % distribution charts can be found below:

* The bar in red indicates where Owens & Minor's ROE % falls into.



Owens & Minor ROE % Calculation

Owens & Minor's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-41.301/( (945.604+924.166)/ 2 )
=-41.301/934.885
=-4.42 %

Owens & Minor's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=71.136/( (886.86+924.166)/ 2 )
=71.136/905.513
=7.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Owens & Minor  (NYSE:OMI) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=71.136/905.513
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(71.136 / 10624.6)*(10624.6 / 5108.6925)*(5108.6925 / 905.513)
=Net Margin %*Asset Turnover*Equity Multiplier
=0.67 %*2.0797*5.6418
=ROA %*Equity Multiplier
=1.39 %*5.6418
=7.86 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=71.136/905.513
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (71.136 / 83.988) * (83.988 / 443.036) * (443.036 / 10624.6) * (10624.6 / 5108.6925) * (5108.6925 / 905.513)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.847 * 0.1896 * 4.17 % * 2.0797 * 5.6418
=7.86 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Owens & Minor ROE % Related Terms

Thank you for viewing the detailed overview of Owens & Minor's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Owens & Minor (Owens & Minor) Business Description

Traded in Other Exchanges
Address
9120 Lockwood Boulevard, Mechanicsville, VA, USA, 23116
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment includes the United States distribution business (Medical Distribution), outsourced logistics and value-added services business, and Global Products business which manufactures and sources medical surgical products through production and kitting operations. The Patient Direct segment includes home healthcare businesses (Byram and Apria).
Executives
Jonathan A Leon officer: SVP, Corporate Treasurer OWENS & MINOR, INC., 9120 LOCKWOOD BLVD, MECHANICSVILLE VA 23116
Perry A Bernocchi officer: EVP & CEO Patient Direct OWENS & MINOR, INC, 9120 LOCKWOOD BLVD, MECHANICSVILLE VA 23116
Heath H Galloway officer: EVP,General Counsel & CorpSecy OWENS & MINOR, INC, 9120 LOCKWOOD BLVD, MECHANICSVILLE VA 23116
Alexander J Bruni officer: EVP, CFO OWENS & MINOR, INC., 9120 LOCKWOOD BLVD, MECHANICSVILLE VA 23116
Edward A Pesicka director, officer: President & CEO 9120 LOCKWOOD BLVD, MECHANICSVILLE VA 23116
Michael Wayne Lowry other: & Interim Chief Acctg Officer 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA 23116
Snehashish Sarkar other: Chief Information Officer OWENS & MINOR INC., 9120 LOCKWOOD BLVD, MECHANICSVILLE VA 23116
Robert J Henkel director C/O OWENS & MINOR, INC., 9120 LOCKWOOD BLVD, MECHANICSVILLE VA 23116
Carissa Rollins director 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Tammy L Gomez officer: EVP, CHRO OWENS & MINOR, INC., 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA 23116
Jeffrey T Jochims officer: EVP, Strategy & Solutions OWENS & MINOR, INC., 9120 LOCKWOOD BLVD, MECHANICSVILLE VA 23116
Rita Johnson-mills director C/O BROOKDALE SENIOR LIVING INC., 111 WESTWOOD PLACE, SUITE 400, BRENTWOOD TN 37027
Teresa L. Kline director C/O INTERSECT ENT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025
Gwendolyn M Bingham director C/O OWENS & MINOR, INC., 9120 LOCKWOOD BLVD, MECHANICSVILLE VA 23116
Daniel J Starck officer: EVP, Pres. Patient Direct, other: & CEO, Apria CORVEL CORPORATION, 2010 MAIN STREET, SUITE 600, IRVINE CA 92614